http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2013003597-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
filingDate 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6928d8a4792fe0dda19e4c22a6e30f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26bc73313581de05a711a7f81fc4b5e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0103650c9db3e0237aef57519ba84e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2c2270d43bb7927a62eb96afcdf351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee9fdcbe707d46f5027bea35b430a0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850a329a7cf7a8e0362187d34f43d449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_698df1540d8f226e0a326862813e8cd7
publicationDate 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2013003597-A1
titleOfInvention Compounds derived from n- [4- (2-oxo-1,2-dihydropyridin-4-yl) benzyl] benzamide; pharmaceutical composition and its use to treat chemical dependence on a dopamine producing agent such as cocaine, opiates, amphetamines, nicotine and alcohol and to treat obesity.
abstract THE INVENTION WILL BE REMOVED FROM A FORMULA COMPOUND (LA): WHICH IS TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF THE CHEMICAL DEPENDENCE OF A DOPARNINE PRODUCING AGENT THAT IS SELECTED FROM THE COCAINE FORMED GROUP, OPOCEANS, ANPHETAMIRIAS A NOLOTINA , OR AN ACCEPTABLE INDEPENDENT SALT, OR PROFÁRNTACO OF THE SAME. THE INVENTION ALSO REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES A THERAPEUTICALLY EFFECTIVE AMOUNT OF SUCH COMPOUND.
priorityDate 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110

Total number of triples: 41.